Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal
info@chv.vc
129 South Street, 4th Floor, Boston, MA 02111
Home
/
News
/
nVision
nVision
Select a Company
Allegro Diagnostics (1)
Aria CV (5)
AtaCor Medical (4)
Augmenix (1)
Biocius (1)
BioTrove (1)
Conformal (13)
GI Dynamics (1)
Sera Prognostics (26)
nVision (1)
Maxwell Health (1)
Vortex Medical (1)
Novazyme Pharmaceuticals (1)
Saphena Medical (3)
Brixton Biosciences (1)
PanTher Therapeutics (5)
Instylla Inc. (3)
Catalyst Health Ventures (2)
Epitel (2)
Avive (2)
Rejoni (1)
Boston Scientific Acquires nVision Medical in $275m Deal
April 16, 2018
-
nVision
Let’s Connect.
Contact Us